Thulasee Jose

Dr. Thulasee Jose

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
TJThulasee Jose
Thulasee Jose
JOJoshua W. Ohde
Joshua W. Ohde
JHJ. Taylor Hays
J. Taylor Hays
MBMichael V. Burke
Michael V. Burke
DWDavid O. Warner
David O. Warner
Continued tobacco use after cancer diagnosis is detrimental to treatment and survivorship. The current reach of evidence-based tobacco treatments in cancer patients is low. As a part of the National Cancer Institute Cancer Center Cessation Initiative, the Mayo Clinic Cancer Center designed an electronic health record (EHR, Epic©)-based process to automatically refer ambulatory oncology patients to tobacco use treatment, regardless of intent to cease tobacco use(“opt out”). The referral and patient scheduling, accomplished through a best practice advisory (BPA) directed to staff who room patients, does not require a co-signature from clinicians. This process was piloted for a six-week period starting in July of 2019 at the Division of Medical Oncology, Mayo Clinic, Rochester, MN. All oncology patients who were tobacco users were referred for tobacco treatment by the rooming staff (n = 210). Of these, 150 (71%) had a tobacco treatment appointment scheduled, and 25 (17%) completed their appointment. We conclude that an EHR-based “opt-out” approach to refer patients to tobacco dependence treatment that does not require active involvement by clinicians is feasible within the oncology clinical practice. Further work is needed to increase the proportion of scheduled patients who attend their appointments.

1 February 2021 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
TJThulasee Jose
Thulasee Jose
DWDavid O. Warner
David O. Warner
JOJohn C. O’hOro
John C. O’hOro
SPSteve G. Peters
Steve G. Peters
RCRajeev Chaudhry
Rajeev Chaudhry
CBCharles D. Burger
Charles D. Burger
To describe the design, implementation and utilization of Electronic Health Record (EHR) based digital health surveillance strategies used to manage the coronavirus disease (COVID-19) pandemic and ensure delivery of high quality clinical care such as case identification, remote monitoring, telemedicine services, and recruitment to clinical trials at Mayo Clinic. Mayo Clinic, a large multistate integrated health care system with over 1.5 million annual patient visits that utilizes the Epic© electronic health record (EHR) system. Rule-based live registries were designed in EHR system to classify patients who 1) are currently tested positive for COVID-19; 2) were tested positive but has recovered from COVID-19; 3) are suspected of COVID-19 but did not yet meet clinical diagnostic criteria,; 4) had tested negative for COVID-19; and 5) exceeded a risk score for serious complications from COVID-19. Using registries, custom dashboards and operational reports were developed to provide daily high-level summary for clinical practice use and provide up to date information used to manage individual patients impacted by COVID-19, including support of case identification, contact isolation and other care management tasks. we developed and implemented a systematic approach for using EHR patient registries to manage the COVID-19 pandemic that proved feasible and useful for managing a large multistate group clinical practice. The key to harnessing the potential of digital surveillance tools to promote patient-centered care during COVID-19 pandemic was to use the registry data, reports and dashboards as informatics tools to inform decision-making.

TJThulasee Jose
Thulasee Jose
JHJ Taylor Hays
J Taylor Hays
DWDavid O. Warner
David O. Warner
The use of electronic cigarettes (e-cigarettes) can affect patient health and clinical care. However, the current documentation of e-cigarette use in the electronic health records (EHR) is inconsistent. This report outlines how the ambulatory clinical practices of a large U.S. hospital system optimized its electronic health records (EHR) framework to better record e-cigarettes used by patients. The new EHR section for e-cigarette information was implemented for outpatient appointments. During a 30-week evaluation period post-implementation, 638,804 patients (12 yrs and older) completed ambulatory appointments within the health system; of these, the new section contained e-cigarette use information for 37,906 (6%) patients. Among these patients, 1005 (2.7%) were identified as current e-cigarette users (current every day or current some day e-cigarette use), 941 (2.5%) were reported as former e-cigarette users, and 35,960 (94%) had never used e-cigarettes. A separate EHR section to document e-cigarette use is feasible within existing clinical practice models. Utilization of the new section was modest in routine clinical practice, indicating the need for more intensive implementation strategies that emphasize the health effects of e-cigarette use, and how consistent ascertainment could improve clinical practice.

28 September 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MFMichael C. Fiore
Michael C. Fiore
SSStevens S. Smith
Stevens S. Smith
RARobert T. Adsit
Robert T. Adsit
DBDaniel M. Bolt
Daniel M. Bolt
KCKaren L. Conner
Karen L. Conner
TBTimothy B. Baker
Timothy B. Baker
Main objective: There is limited information on how patient outcomes have changed during the COVID-19 pandemic. This study characterizes changes in mortality, intubation, and ICU admission rates during the first 20 months of the pandemic. Study design and methods: University of Wisconsin researchers collected and harmonized electronic health record data from 1.1 million COVID-19 patients across 21 United States health systems from February 2020 through September 2021. The analysis comprised data from 104,590 adult hospitalized COVID-19 patients. Inclusion criteria for the analysis were: (1) age 18 years or older; (2) COVID-19 ICD-10 diagnosis during hospitalization and/or a positive COVID-19 PCR test in a 14-day window (+/- 7 days of hospital admission); and (3) health system contact prior to COVID-19 hospitalization. Outcomes assessed were: (1) mortality (primary), (2) endotracheal intubation, and (3) ICU admission. Results and significance: The 104,590 hospitalized participants had a mean age of 61.7 years and were 50.4% female, 24% Black, and 56.8% White. Overall risk-standardized mortality (adjusted for age, sex, race, ethnicity, body mass index, insurance status and medical comorbidities) declined from 16% of hospitalized COVID-19 patients (95% CI: 16% to 17%) early in the pandemic (February-April 2020) to 9% (CI: 9% to 10%) later (July-September 2021). Among subpopulations, males (vs. females), those on Medicare (vs. those on commercial insurance), the severely obese (vs. normal weight), and those aged 60 and older (vs. younger individuals) had especially high mortality rates both early and late in the pandemic. ICU admission and intubation rates also declined across these 20 months. Conclusions: Mortality, intubation, and ICU admission rates improved markedly over the first 20 months of the pandemic among adult hospitalized COVID-19 patients although gains varied by subpopulation. These data provide important information on the course of COVID-19 and identify hospitalized patient groups at heightened risk for negative outcomes. Trial registration: ClinicalTrials.gov Identifier: NCT04506528 (https://clinicaltrials.gov/ct2/show/NCT04506528).

9 August 2022 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
MNMargaret Nolan
Margaret Nolan
TPThomas M. Piasecki
Thomas M. Piasecki
SSStevens S. Smith
Stevens S. Smith
TBTimothy B. Baker
Timothy B. Baker
MFMichael C. Fiore
Michael C. Fiore
WSWendy S. Slutske
Wendy S. Slutske
Background: There is mixed evidence about the relations of current versus past cancer with severe COVID-19 outcomes and how they vary by patient and cancer characteristics. Methods: Electronic health record data of 104,590 adult hospitalized patients with COVID-19 were obtained from 21 United States health systems from February 2020 through September 2021. In-hospital mortality and ICU admission were predicted from current and past cancer diagnoses. Moderation by patient characteristics, vaccination status, cancer type, and year of the pandemic was examined. Results: 6.8% of the patients had current (n = 7,141) and 6.5% had past (n = 6,749) cancer diagnoses. Current cancer predicted both severe outcomes but past cancer did not; adjusted odds ratios (aOR) for mortality were 1.58 [95% confidence interval (CI), 1.46–1.70] and 1.04 (95% CI, 0.96–1.13), respectively. Mortality rates decreased over the pandemic but the incremental risk of current cancer persisted, with the increment being larger among younger vs. older patients. Prior COVID-19 vaccination reduced mortality generally and among those with current cancer (aOR, 0.69; 95% CI, 0.53–0.90). Conclusions: Current cancer, especially among younger patients, posed a substantially increased risk for death and ICU admission among patients with COVID-19; prior COVID-19 vaccination mitigated the risk associated with current cancer. Past history of cancer was not associated with higher risks for severe COVID-19 outcomes for most cancer types. Impact: This study clarifies the characteristics that modify the risk associated with cancer on severe COVID-19 outcomes across the first 20 months of the COVID-19 pandemic. See related commentary by Egan et al., p. 3

1 June 2020 in Journal of PeriAnesthesia Nursing
Verified
Journal Article
Closed access
TJThulasee Jose
Thulasee Jose
MMManda McNamara
Manda McNamara
MBMegan L. Barrone
Megan L. Barrone
WJWendy S. Johnson
Wendy S. Johnson
HLHeather A. Larsen
Heather A. Larsen
DWDavid O. Warner
David O. Warner